tert-Butyl 9-amino-2-azaspiro[5.5]undecane-2-carboxylate

Catalog No.: 
ACTOFN431
CAS No.: 
1779849-06-7
Molecular Formula: 
C15H28N2O2
Molecular Weight: 
268.40
tert-Butyl 9-amino-2-azaspiro[5.5]undecane-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$436.00In stockInquiry
250mg98%$696.00In stockInquiry
1g98%$1686.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 9-amino-2-azaspiro[5.5]undecane-2-carboxylate
IUPAC Nametert-butyl 9-amino-2-azaspiro[5.5]undecane-2-carboxylate
MDL No.MFCD30471102
Molecular FormulaC15H28N2O2
Molecular Weight268.40
SMILESO=C(N1CC2(CCC(N)CC2)CCC1)OC(C)(C)C
InChI KeyUGZDVGXHGQBSQM-UHFFFAOYSA-N
SynonymTERT-BUTYL 9-AMINO-2-AZASPIRO[5.5]UNDECANE-2-CARBOXYLATE
CAS No.1779849-06-7

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H315-H318-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338-P310-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTOFN431 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXRFO639 route compound structure diagram
    ACXRFO6391434142-14-9In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACTOFN431 route product structure diagram
    ACTOFN4311779849-06-7In Stock
Inquiry

2. ACTOFN431 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTOFN431 route product structure diagram
    ACTOFN4311779849-06-7In Stock
Inquiry

3. ACTOFN431 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTOFN431 route product structure diagram
    ACTOFN4311779849-06-7In Stock
Inquiry

Comments (0)